These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10548188)

  • 1. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group.
    Reeves JH; Butt WW; Shann F; Layton JE; Stewart A; Waring PM; Presneill JJ
    Crit Care Med; 1999 Oct; 27(10):2096-104. PubMed ID: 10548188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
    Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood filtration in children with severe sepsis: safe adjunctive therapy.
    Reeves JH; Butt WW
    Intensive Care Med; 1995 Jun; 21(6):500-4. PubMed ID: 7560493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The organ protective effects and timing of continuous blood purification in the treatment of severe sepsis：a double-blind randomized controlled trial].
    Zhou R; Weng F; Dai W; Yan J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):241-5. PubMed ID: 29917338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.
    Parsons PE; Eisner MD; Thompson BT; Matthay MA; Ancukiewicz M; Bernard GR; Wheeler AP;
    Crit Care Med; 2005 Jan; 33(1):1-6; discussion 230-2. PubMed ID: 15644641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar Metabolic, Innate Immunity, and Adipokine Profiles in Adult and Pediatric Sepsis Versus Systemic Inflammatory Response Syndrome-A Pilot Study.
    Tavladaki T; Spanaki AM; Dimitriou H; Kondili E; Choulaki C; Georgopoulos D; Briassoulis G
    Pediatr Crit Care Med; 2017 Nov; 18(11):e494-e505. PubMed ID: 28816920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
    Cole L; Bellomo R; Hart G; Journois D; Davenport P; Tipping P; Ronco C
    Crit Care Med; 2002 Jan; 30(1):100-6. PubMed ID: 11902250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
    Abraham E; Wunderink R; Silverman H; Perl TM; Nasraway S; Levy H; Bone R; Wenzel RP; Balk R; Allred R
    JAMA; 1995 Mar 22-29; 273(12):934-41. PubMed ID: 7884952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
    Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A
    JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of sepsis and multiple organ dysfunction syndrome in children.
    Proulx F; Fayon M; Farrell CA; Lacroix J; Gauthier M
    Chest; 1996 Apr; 109(4):1033-7. PubMed ID: 8635327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis.
    Pettilä V; Pentti J; Pettilä M; Takkunen O; Jousela I
    Crit Care Med; 2002 Feb; 30(2):271-5. PubMed ID: 11889291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
    Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
    Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis.
    Yekebas EF; Eisenberger CF; Ohnesorge H; Saalmüller A; Elsner HA; Engelhardt M; Gillesen A; Meins J; The M; Strate T; Busch C; Knoefel WT; Bloechle C; Izbicki JR
    Crit Care Med; 2001 Jul; 29(7):1423-30. PubMed ID: 11445702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.
    Rey C; Los Arcos M; Concha A; Medina A; Prieto S; Martinez P; Prieto B
    Intensive Care Med; 2007 Mar; 33(3):477-84. PubMed ID: 17260130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis.
    Borgel D; Clauser S; Bornstain C; Bièche I; Bissery A; Remones V; Fagon JY; Aiach M; Diehl JL
    Crit Care Med; 2006 Jan; 34(1):219-22. PubMed ID: 16374177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group.
    Knaus WA; Harrell FE; LaBrecque JF; Wagner DP; Pribble JP; Draper EA; Fisher CJ; Soll L
    Crit Care Med; 1996 Jan; 24(1):46-56. PubMed ID: 8565538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients.
    Zakynthinos SG; Papanikolaou S; Theodoridis T; Zakynthinos EG; Christopoulou-Kokkinou V; Katsaris G; Mavrommatis AC
    Crit Care Med; 2004 Apr; 32(4):1004-10. PubMed ID: 15071393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study.
    Yu M; Levy MM; Smith P; Takiguchi SA; Miyasaki A; Myers SA
    Crit Care Med; 1993 Jun; 21(6):830-8. PubMed ID: 8504649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.
    Abraham E; Laterre PF; Garbino J; Pingleton S; Butler T; Dugernier T; Margolis B; Kudsk K; Zimmerli W; Anderson P; Reynaert M; Lew D; Lesslauer W; Passe S; Cooper P; Burdeska A; Modi M; Leighton A; Salgo M; Van der Auwera P;
    Crit Care Med; 2001 Mar; 29(3):503-10. PubMed ID: 11373411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.